Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 1.850
0.00 (0.00%)
At close: Nov 20, 2024
NEIMETH Cash Flow Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Net Income | -1,983 | -2,865 | -325.04 | -109.66 | 270.58 | 212.48 | Upgrade
|
| Depreciation & Amortization | 147.78 | 126.09 | 115.96 | 119.57 | 107.93 | 110.72 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.97 | -0.97 | - | - | -4.86 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | -4.58 | Upgrade
|
| Provision & Write-off of Bad Debts | -444.76 | -449.84 | 45.2 | 19.2 | 59.03 | - | Upgrade
|
| Other Operating Activities | 751.62 | 473.65 | 260.84 | 53.07 | 73.22 | 501.13 | Upgrade
|
| Change in Accounts Receivable | 440.14 | 997.64 | -137.71 | -6.92 | -309.15 | 6.35 | Upgrade
|
| Change in Inventory | -94.25 | -346.13 | -203.78 | -267.21 | -25.27 | -666.4 | Upgrade
|
| Change in Accounts Payable | 1,656 | 1,304 | 378.1 | 213.8 | 79.86 | 226.19 | Upgrade
|
| Change in Other Net Operating Assets | -17.05 | -12.03 | -1.02 | -83.61 | 23.16 | -25.02 | Upgrade
|
| Operating Cash Flow | 456.18 | -773.41 | 132.55 | -61.76 | 346.03 | 302.53 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 14.38% | -2.78% | Upgrade
|
| Capital Expenditures | -833.45 | -936.14 | -1,270 | -1,143 | -344.07 | -564.05 | Upgrade
|
| Sale of Property, Plant & Equipment | -11.68 | 2.25 | - | - | 4.86 | - | Upgrade
|
| Investing Cash Flow | -845.12 | -933.89 | -1,270 | -1,143 | -339.21 | -564.05 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 913.16 | - | 519.27 | Upgrade
|
| Long-Term Debt Issued | - | 40.64 | - | - | - | 2,750 | Upgrade
|
| Total Debt Issued | 40.64 | 40.64 | 2,243 | 913.16 | - | 3,269 | Upgrade
|
| Long-Term Debt Repaid | - | -214.58 | - | -537.12 | -334.28 | -294.23 | Upgrade
|
| Total Debt Repaid | 169.52 | -214.58 | -1,888 | -537.12 | -334.28 | -294.23 | Upgrade
|
| Net Debt Issued (Repaid) | 210.16 | -173.95 | 354.58 | 376.04 | -334.28 | 2,975 | Upgrade
|
| Issuance of Common Stock | 30.85 | 3,710 | - | - | - | - | Upgrade
|
| Common Dividends Paid | - | - | -106.35 | -132.94 | -123.45 | - | Upgrade
|
| Other Financing Activities | -958.75 | -816.02 | -358.37 | -239.52 | -182.33 | -156.59 | Upgrade
|
| Financing Cash Flow | -717.74 | 2,721 | -110.15 | 3.58 | -640.06 | 2,818 | Upgrade
|
| Foreign Exchange Rate Adjustments | 790.67 | 791.25 | -3.43 | 0 | 10.1 | 4.09 | Upgrade
|
| Net Cash Flow | -316.01 | 1,804 | -1,251 | -1,201 | -623.14 | 2,561 | Upgrade
|
| Free Cash Flow | -377.26 | -1,710 | -1,137 | -1,205 | 1.96 | -261.53 | Upgrade
|
| Free Cash Flow Margin | -9.95% | -77.37% | -38.95% | -44.57% | 0.06% | -9.21% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.40 | -0.60 | -0.63 | 0.00 | -0.14 | Upgrade
|
| Cash Interest Paid | 886.26 | 667.95 | 300 | 181.77 | 188.22 | 212.76 | Upgrade
|
| Cash Income Tax Paid | 69.28 | 125.84 | 53.76 | 31.81 | 81.18 | 42.93 | Upgrade
|
| Levered Free Cash Flow | 784.24 | 54.7 | - | -1,309 | -164.78 | -506.33 | Upgrade
|
| Unlevered Free Cash Flow | 1,338 | 472.17 | - | -1,195 | -47.15 | -373.36 | Upgrade
|
| Change in Net Working Capital | -1,842 | -1,763 | - | 156.54 | 153.97 | 356.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.